West Pharmaceutical Services, Inc. (WST)
NYSE
Real-time Data
01:30 PM
Day's Range
349.7052 wk Range
223.83Overview - WST - West Pharmaceutical Services, Inc.
Key Statistics
Valuation
Enterprise Value
24.72B
P/E (Trailing)
‪45.26‬
P/E (Forward)
‪35.43‬
PEG Ratio
‪2.35‬
Price / Sales (TTM)
‪7.46‬
Price / Book
‪8.31‬
EV / EBITDA
‪27.10‬
Profitability
Gross Margin
‪37.73%‬
Profit Margin
‪16.98%‬
Operating Margin
‪22.46%‬
Return on Assets
‪11.37%‬
Return on Equity
‪19.08%‬
Ownership
Shares Outstanding
70.40M
Float
69.86M
Short % of Shares Outstanding
‪4.17%‬
Held by Insiders
‪0.64%‬
Held by Institutions
‪102.10%‬
Price stats
Beta
‪1.13‬
50-Day Avg
‪347.81‬
200-Day Avg
‪290.20‬
Dividends
Payout Ratio
‪11.14%‬
Frequency
Quarterly
Analyst Consensus
16 analysts
Average price target
‪$ 404.73‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - WST - West Pharmaceutical Services, Inc.
Peers - WST - West Pharmaceutical Services, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - WST - West Pharmaceutical Services, Inc.
About
West Pharmaceutical Services, Inc. is a healthcare manufacturing company that develops and produces containment and delivery solutions for injectable medicines and other pharmaceutical products. Its offerings include packaging components, seals, stoppers, plungers, drug delivery systems, and specialized containment…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
